Your browser doesn't support javascript.
loading
Genomic landscape of Epstein-Barr virus-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue.
Rea, Bryan; Liu, Yen-Chun; Maguire, Alanna; Soma, Lorinda A; Bacon, Chris M; Bayerl, Michael G; Smith, Molly H; Barrett, Michael T; Swerdlow, Steven H; Gibson, Sarah E.
Afiliação
  • Rea B; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Liu YC; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Maguire A; Department of Research, Mayo Clinic Arizona, Scottsdale, AZ, USA.
  • Soma LA; University of Washington Medical Center, Seattle, WA, USA.
  • Bacon CM; Translational and Clinical Research Institute, Newcastle University, and Department of Cellular Pathology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
  • Bayerl MG; Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.
  • Smith MH; University of Kentucky College of Dentistry, Lexington, KY, USA.
  • Barrett MT; Department of Research, Mayo Clinic Arizona, Scottsdale, AZ, USA.
  • Swerdlow SH; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
  • Gibson SE; University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. Gibson.Sarah@mayo.edu.
Mod Pathol ; 35(7): 938-945, 2022 07.
Article em En | MEDLINE | ID: mdl-34952945
ABSTRACT
Epstein-Barr virus (EBV)-positive extranodal marginal zone lymphomas of mucosa-associated lymphoid tissue (MALT lymphomas) were initially described in solid organ transplant recipients, and, more recently, in other immunodeficiency settings. The overall prevalence of EBV-positive MALT lymphomas has not been established, and little is known with respect to their genomic characteristics. Eight EBV-positive MALT lymphomas were identified, including 1 case found after screening a series of 88 consecutive MALT lymphomas with EBER in situ hybridization (1%). The genomic landscape was assessed in 7 of the 8 cases with a targeted high throughput sequencing panel and array comparative genomic hybridization. Results were compared to published data for MALT lymphomas. Of the 8 cases, 6 occurred post-transplant, 1 in the setting of primary immunodeficiency, and 1 case was age-related. Single pathogenic/likely pathogenic mutations were identified in 4 of 7 cases, including mutations in IRF8, BRAF, TNFAIP3, and SMARCA4. Other than TNFAIP3, these genes are mutated in <3% of EBV-negative MALT lymphomas. Copy number abnormalities were identified in 6 of 7 cases with a median of 6 gains and 2 losses per case, including 4 cases with gains in regions encompassing several IRF family or interacting genes (IRF2BP2, IRF2, and IRF4). There was no evidence of trisomies of chromosomes 3 or 18. In summary, EBV-positive MALT lymphomas are rare and, like other MALT lymphomas, are usually genetically non-complex. Conversely, while EBV-negative MALT lymphomas typically show mutational abnormalities in the NF-κB pathway, other than the 1 TNFAIP3-mutated case, no other NF-κB pathway mutations were identified in the EBV-positive cases. EBV-positive MALT lymphomas often have either mutations or copy number abnormalities in IRF family or interacting genes, suggesting that this pathway may play a role in these lymphomas.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B / Infecções por Vírus Epstein-Barr Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Mod Pathol Assunto da revista: PATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B / Infecções por Vírus Epstein-Barr Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Mod Pathol Assunto da revista: PATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos